|1.||Zhang, Jian X: 5 articles (12/2009 - 03/2003)|
|2.||Dogné, Jean-Michel: 5 articles (09/2009 - 01/2002)|
|3.||Huang, Run-Yue: 4 articles (01/2015 - 04/2011)|
|4.||Wu, Qiang: 3 articles (12/2015 - 04/2014)|
|5.||He, Guangwei: 3 articles (12/2015 - 04/2014)|
|6.||Fang, Weirong: 3 articles (12/2015 - 04/2014)|
|7.||Chu, Shaoxing: 3 articles (12/2015 - 04/2014)|
|8.||Li, Yunman: 3 articles (12/2015 - 04/2014)|
|9.||Violi, Francesco: 3 articles (10/2015 - 10/2004)|
|10.||Yalcin, Murat: 3 articles (05/2014 - 11/2006)|
06/30/1989 - "This study suggests that males exposed to LPS may generate more thromboxane A2 than females and thus be at higher risk of developing thrombosis."
12/01/2015 - "Thromboxane A2 (TXA2) can induce the platelet aggregation and lead to thrombosis. "
08/15/2003 - "Thromboxane A2 (TXA2)-mediated platelet secretion and aggregation are important in thrombosis. "
01/01/1996 - "These observations thus suggest that microcirculatory disturbances by platelet thrombus, which are mediated by thromboxane A2 at least in part, play an important role in ETX-induced intestinal damage."
09/01/1991 - "The thromboxane A2 antagonist SQ29548 (100 mg/kg/min iv) resulted in a significant delay in platelet thrombus formation in arterioles and venules. "
04/01/1993 - "Although previous studies have already documented the increased release of cardiac thromboxane A2 after ischemia, none have studied the effects of cardiac thromboxane A2 on hemodynamics. "
12/01/1990 - "Our previous studies demonstrated that the bilateral hindlimb ischemia/reperfusion stimulates thromboxane A2 (TXA2) production. "
12/01/1983 - "In this study, the thesis that ischemia of the limb is a significant stimulus to thromboxane A2 synthesis and the generation of a circulating negative inotrope is tested. "
09/01/1998 - "Suppression of cytokine production by thromboxane A2 inhibitor in liver ischemia."
07/01/1996 - "Thromboxane A2 accumulates in the hippocampus after global ischemia and may play a key role in postischemic hypoperfusion. "
|3.||Pathologic Constriction (Stenosis)
04/01/1992 - "Even during hypoperfusion produced by a flow limiting arterial stenosis, the coronary resistance vessels remain responsive to the vasoconstrictor effect of thromboxane A2. "
04/01/1992 - "The aim was to test the hypothesis that thromboxane A2 can cause vasoconstriction of coronary resistance vessels during exercise in hypoperfused regions of myocardium distal to an arterial stenosis. "
12/01/1985 - "This study tested the hypothesis that aggregation of platelets and release of thromboxane A2 at the site of a coronary arterial stenosis may contribute to myocardial ischemia by impairing flow regulation of the distal coronary bed. "
11/01/1986 - "These data suggest that the thromboxane A2/PGH2 receptor antagonists, SQ29,548 and SQ28,688, inhibit cyclic reductions in coronary blood flow in this model by preventing the accumulation of platelets at the site of a critical coronary arterial stenosis. "
06/01/2000 - "This exercise-induced vasoconstriction has been associated with the occurrence of myocardial ischemia and has been believed to be the result of endothelial dysfunction, with a reduced release or production of EDRF, increased sympathetic stimulation, enhanced platelet aggregation with release of thromboxane A2 and serotonin, or a passive collapse of the disease-free wall segment within the stenosis (the Bernoulli effect), or a combination of any of these. "
09/01/2014 - "N2 ameliorates neural injury during experimental ischemic stroke via the regulation of thromboxane A2 production."
09/01/2014 - "Thromboxane A2 (TXA2) promotes ischemic stroke injury and has strong effects in vascular contraction and vascular endothelial cell dysfunction. "
04/01/2014 - "Thromboxane A2 (TXA2) induces platelet aggregation and vasoconstriction, and agents that inhibit TXA2 production or interaction with receptors may exert potential application in stroke therapy. "
09/01/1988 - "Our results support a possible role for thromboxane A2 in the elevation of blood pressure in SHRSP but do not support a possible role for the prevention of stroke by thromboxane A2 synthase inhibition in these rats."
09/01/1988 - "Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats."
|5.||Myocardial Ischemia (Ischemic Heart Diseases)
12/01/2008 - "Myocardial ischemia-mediated excitatory reflexes: a new function for thromboxane A2?"
08/01/1989 - "Increased Ca2+ influx into platelets induced by thromboxane A2 analog in patients with ischemic heart disease."
11/01/1987 - "Thromboxane A2 (TxA2) production increases significantly during acute myocardial ischemia. "
01/01/1986 - "Potentiation of thromboxane A2 release might contribute to myocardial ischemia associated with platelet activation."
12/01/1985 - "Thromboxane A2 (TxA2) production increases significantly during acute myocardial ischemia. "
|2.||Serotonin (5 Hydroxytryptamine)
|3.||Aspirin (Acetylsalicylic Acid)
|6.||Arachidonic Acid (Vitamin F)
|7.||Prostaglandin H2 (PGH(2))
|10.||Tissue Plasminogen Activator (Alteplase)
|1.||Blood Component Removal (Apheresis)
|4.||Surgical Instruments (Clip)